September 1, 2016
View Full PaperTAVI with current CE-marked devices: strategies for optimal sizing and valve delivery
Key Result
This review provides a practical overview of current CE-marked transcatheter heart valves for severe aortic stenosis, focusing on respective sizing algorithms and delivery strategies.
Structured PICO
P
Population
Patients with severe aortic stenosis
I
Intervention
Transcatheter aortic valve implantation (TAVI) with current CE-marked transcatheter heart valves
This review provides a practical overview of current CE-marked transcatheter heart valves, focusing on sizing algorithms and delivery strategies for severe aortic stenosis.
Abstract
Transcatheter aortic valve implantation (TAVI) has evolved from an exclusive, highly complex and hazardous procedure into a mature, safe and streamlined therapy for patients with severe aortic stenosis (AS). Various successive device iterations and product refinements have created a dynamic and competitive field with a spectrum of different CE-marked transcatheter heart valve (THV) designs. This review provides a practical overview of current CE-marked THVs with a focus on respective sizing algorithms and delivery strategies.